J. Receveur

发表

Effects of MCH and a MCH1-receptor antagonist on (palatable) food and water intake

G. V. Dijk, A. Scheurink, C. Morens, 2005, Brain Research.

4‐Acylamino‐ and 4‐Ureidobenzamides as Melanin‐Concentrating Hormone (MCH) Receptor 1 Antagonists

T. Ulven, J. Receveur, P. Little, 2005 .

Conversion of 4‐Cyanomethyl‐pyrazole‐3‐carboxamides into CB1 Antagonists with Lowered Propensity to Pass the Blood—Brain‐Barrier.

J. Linget, A. Murray, J. Receveur, 2010 .

Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonists.

T. Högberg, Pia K Nørregaard, J. Receveur, 2010, Bioorganic & medicinal chemistry letters.

Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists.

T. Frimurer, J. M. Mathiesen, T. Högberg, 2010, Bioorganic & medicinal chemistry letters.

Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 2.

T. Frimurer, J. M. Mathiesen, E. Kostenis, 2010, Bioorganic & medicinal chemistry letters.

Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 1.

T. Frimurer, E. Kostenis, T. Högberg, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of glutamic acid derivatives.

M. Récasens, J. Guiramand, J. Receveur, 1998, Bioorganic & medicinal chemistry letters.

Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.

Evi Kostenis, Thomas M Frimurer, Trond Ulven, 2006, Journal of medicinal chemistry.

Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier.

Martin Cooper, Anthony Murray, T. Högberg, 2010, Bioorganic & medicinal chemistry letters.

Impurity Dimethylcarbamoyl-OBt Detected in an API Induced by the Degradation of HBTU in DMF

Yi Yang, Jörgen Sjögren, J. Receveur, 2021, Organic Process Research & Development.

Neuroexcitatory amino acids: 4-methylene glutamic acid derivatives

J. Receveur, M. Roumestant, P. Viallefont, 1995, Amino Acids.

An in vitro investigation into conformational aspects of gabapentin.

J. Rubin, J. Bryans, D. Horwell, 1999, Bioorganic & medicinal chemistry.

Contrasted conditions of reinforcement: the effects of bidirectional changes in the incentive value of reward

J. Receveur, 1985 .

6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.

Thomas M Frimurer, Trond Ulven, T. Frimurer, 2005, Journal of medicinal chemistry.

Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.

T. Frimurer, I. Khanna, T. Högberg, 2010, Bioorganic & medicinal chemistry letters.

6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: structure-activity exploration of eastern and western parts.

T. Frimurer, T. Högberg, T. Ulven, 2006, Bioorganic & medicinal chemistry letters.

Synthesis of Structurally Diversified α-Substituted β-Amino Acids and Derivatives via Conjugate Radical Additions and Heck Reactions.

Jean Martínez, J. Receveur, Marie-Louise Roumestant, 2002 .

4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.

Trond Ulven, T. Högberg, T. Ulven, 2004, Bioorganic & medicinal chemistry letters.

Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists.

T. Frimurer, J. M. Mathiesen, T. Högberg, 2010, Bioorganic & medicinal chemistry letters.